Green Enantioselective Halogenation for Drug Discovery and Manufacture (H2020-MSCA-RISE-823939)
The aim of this project is to bring together subject matter experts from the academic and non-academic sectors to develop and exemplify the use of new catalysts and new green reactions to manufacture important halogenated compounds that could be used in drug discovery and drug production. In order to achieve this objective the proposal brings together 3 partners with complementary skills:
– University of Naples (UNINA): expertise in medicinal chemistry and drug discovery.
– KelAda Pharmachem: expertise in green chemistry, chemical batch process development and scale-up.
– University of Cordoba (UCO): expertise in process engineering of continuous flow processes.
OBJETIVOS GENERALES
– Objective 1: Development of new, efficient “green” organocatalysts.
– Objective 2: Exemplification of utility these catalysts to create a halogenation platform.
– Objective 3: Synthesis (using halogenation platform) and testing of drug candidates.
– Objective 4: Scale-up of syntheses of key compounds in order to demonstrate industrial viability.
PAPEL DE LA UNIVERSIDAD DE CÓRDOBA
The University of Cordoba is in charge of the Work Programme 4: Development of continuous flow variants and scale up.
DATOS DE CONTACTO
Investigador Principal: Rafael Luque Álvarez de Sotomayor
Correo electrónico de contacto: q62alsor@uco.es
Página web del proyecto (enlace CORDIS): https://cordis.europa.eu/project/id/823939/es